Pasithea Therapeutics Corp Warrant
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $649 | $0 |
Gross Profit | -161 | -161 | 324 | -162 |
EBITDA | -3,649 | -3,401 | -3,097 | -2,842 |
EBIT | -3,810 | -3,563 | -3,259 | -3,004 |
Net Income | -3,716 | -3,563 | -3,177 | -2,999 |
Net Change In Cash | 0 | 0 | 649 | 0 |
Free Cash Flow | -3,868 | -3,055,757 | -2,443 | -3,120 |
Cash | 7,217 | 5,341 | 6,922 | 9,361 |
Basic Shares | 5,641 | 1,096 | 1,096 | 1,044 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $486 | $486 | $15 |
Gross Profit | -649 | -648 | 373 | -2 |
EBITDA | -13,255 | -15,330 | -12,583 | -4,506 |
EBIT | -13,904 | -15,979 | -12,588 | -4,507 |
Net Income | -13,904 | -15,961 | -13,056 | -2,174 |
Net Change In Cash | 0 | 486 | 486 | 15 |
Free Cash Flow | -13,923,438 | -12,848 | -16,700 | -3,195 |
Cash | 6,922 | 16,331 | 33,146 | 52,966 |
Basic Shares | 1,096 | 1,226 | 1,262 | 1,150 |
